Return to homepagePandemic Pact

Montreal Heart Institute COLCORONA Trial: Mild Disease Treatment Using Colchicine

  • Funded by Gates Foundation, Wellcome Trust
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Gates Foundation, Wellcome Trust

  • Principal Investigator

    Unspecified Unspecified Unspecified

  • Research Location

    United States of America, Brazil
    …

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Started in March in Quebec and has since expanded to Spain, New York and California. This trial is targeting 6,000 outpatients using Colchicine to treat mild COVID-19. Given positive interim read-outs in June, this trial is expending to Brazil, Argentina and South Africa. ~37% enrollment completed.